Guard Therapeutics International AB Cash Flow Conversion Efficiency

Latest as of September 2025: -1.630x

Guard Therapeutics International AB cash flow conversion efficiency. Based on the latest financial reports, Guard Therapeutics International AB (GUARD) has a cash flow conversion efficiency ratio of -1.630x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-90.70 Million ≈ $-9.76 Million USD) by net assets (Skr55.63 Million ≈ $5.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Guard Therapeutics International AB (2012–2024)

Cash flow conversion efficiency of Guard Therapeutics International AB from 2012 to 2024. This chart illustrates how Guard Therapeutics International AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Guard Therapeutics International AB (GUARD) stock price for real-time trading data and today's change.

Guard Therapeutics International AB Cash Flow Conversion Ratio Explained

Guard Therapeutics International AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Guard Therapeutics International AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guard Therapeutics International AB ranked by their cash flow conversion efficiency. Also see market cap of Guard Therapeutics International AB for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
CHRISTINA LAKE CANNABIS F:CLB	0.102x
Airtouch Solar Ltd TA:ARTS	-0.049x
Hanil Vacuum Co. Ltd KQ:123840	-0.052x
Banzai International, Inc. NASDAQ:PARA	-0.316x
De La Rue PLC LSE:DLAR	2.021x
Bilici Yatirim Sanayi ve Ticaret AS IS:BLCYT	-0.021x
Vaxtex Cotfab Limited NSE:VCL	-0.091x
Ecobuilt Holdings Bhd KLSE:0059	-0.056x

Annual Cash Flow Conversion Efficiency for Guard Therapeutics International AB (2012–2024)

The table below shows the annual cash flow conversion efficiency of Guard Therapeutics International AB from 2012 to 2024. Review Guard Therapeutics International AB free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr37.97 Million ≈ $4.09 Million	Skr-94.75 Million ≈ $-10.20 Million	-2.496x	-43.52%
2023-12-31	Skr66.73 Million ≈ $7.18 Million	Skr-116.05 Million ≈ $-12.49 Million	-1.739x	-201.96%
2022-12-31	Skr177.36 Million ≈ $19.09 Million	Skr-102.14 Million ≈ $-10.99 Million	-0.576x	-30.46%
2021-12-31	Skr175.78 Million ≈ $18.92 Million	Skr-77.59 Million ≈ $-8.35 Million	-0.441x	+7.34%
2020-12-31	Skr79.69 Million ≈ $8.58 Million	Skr-37.96 Million ≈ $-4.09 Million	-0.476x	+58.36%
2019-12-31	Skr52.62 Million ≈ $5.66 Million	Skr-60.21 Million ≈ $-6.48 Million	-1.144x	-105.75%
2018-12-31	Skr-2.94 Million ≈ $-316.28K	Skr-58.46 Million ≈ $-6.29 Million	19.890x	+1063.17%
2017-12-31	Skr31.96 Million ≈ $3.44 Million	Skr-66.01 Million ≈ $-7.10 Million	-2.065x	-33.35%
2016-12-31	Skr30.34 Million ≈ $3.26 Million	Skr-46.98 Million ≈ $-5.06 Million	-1.549x	-123.61%
2015-12-31	Skr42.69 Million ≈ $4.59 Million	Skr-29.56 Million ≈ $-3.18 Million	-0.693x	-427.08%
2014-12-31	Skr52.25 Million ≈ $5.62 Million	Skr-6.87 Million ≈ $-738.89K	-0.131x	-18.18%
2013-12-31	Skr25.42 Million ≈ $2.74 Million	Skr-2.83 Million ≈ $-304.12K	-0.111x	-134.81%
2012-12-31	Skr30.58 Million ≈ $3.29 Million	Skr-1.45 Million ≈ $-155.83K	-0.047x	--

About Guard Therapeutics International AB

ST:GUARD Sweden Biotechnology

Market Cap

$3.19 Million

Skr29.61 Million SEK

Market Cap Rank

#29367 Global

#662 in Sweden

Share Price

Skr1.47

Change (1 day)

+1.24%

52-Week Range

Skr0.95 - Skr2.35

All Time High

Skr3260.75